نتائج البحث - "Patrick Hayden"

1

Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—The DIADEM study from the chronic malignancies working party of the EBMT

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9)

المصدر: Bone marrow transplantation
Bone Marrow Transplantation, 58(4), 424-429. Nature Publishing Group

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7859a2c9f506d9b389a43f6bf0d05bfTest
https://doi.org/10.1038/s41409-023-01915-7Test

2

Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis

المصدر: Blood, 140(12), 1408-1418. AMER SOC HEMATOLOGY

مصطلحات موضوعية: Adult, Male, Adolescent, Immunology, Hematopoietic Stem Cell Transplantation, Leukemia, Myelomonocytic, Chronic, Cell Biology, Hematology, Middle Aged, Biochemistry, Young Adult, Leukemia, Myelomonocytic, Juvenile, Humans, Transplantation, Homologous, Aged, Retrospective Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63de466d5e61bdb9ee22dd9315c2f65cTest
https://hdl.handle.net/1887/3564265Test

3

Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

المساهمون: UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service d'hématologie

المصدر: Bone marrow transplantation, Vol. 57, no.2, p. 261-270 (2022)
BONE MARROW TRANSPLANTATION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b716cad90a557c3939ea2ea72cecdcTest
https://hdl.handle.net/2078.1/261776Test

4

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

المساهمون: Universidad de Cantabria, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Mayo Clinic [Rochester], Clínica Universidad de Navarra [Pamplona], Freiburg University Medical Center, The Levine Cancer Institute, Université de Liège, University of Oslo (UiO), University of Pavia, Columbia University [New York], Hospital Universitario de Salamanca, Servicio de Haematologia, Service d'hématologie clinique et de thérapie cellulaire [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Centre hospitalier universitaire de Nantes (CHU Nantes), Erasmus University Medical Center [Rotterdam] (Erasmus MC), University of Maryland [Baltimore], Karolinska Institutet [Stockholm], Heidelberg University Hospital [Heidelberg], University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), University Hospital of Würzburg, Samuel Oschin Comprehensive Cancer Institute, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, The institute of cancer research [London], Instituto de Salud Carlos III, Ministerio de Sanidad (España), European Commission, Generalitat de Catalunya, Hematology

المصدر: Blood Cancer J . 2021 Dec 2;11(12):192
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Blood Cancer Journal
Blood Cancer Journal, Nature Publishing Group, 2021, 11 (12), ⟨10.1038/s41408-021-00587-0⟩
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-5 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Blood Cancer Journal, 11(12):192. Nature Publishing Group

مصطلحات موضوعية: Male, Cell biology, medicine.medical_specialty, Plasma Cells, Myeloma, macromolecular substances, Disease, Plasma cell, Gastroenterology, Article, Leukemia, Plasma Cell, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Effective treatment, In patient, Cancer genetics, RC254-282, Multiple myeloma, Aged, Retrospective Studies, Plasma cell leukemia, business.industry, technology, industry, and agriculture, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hematology, Prognosis, equipment and supplies, musculoskeletal system, medicine.disease, Peripheral blood, 3. Good health, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, 030215 immunology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3212fab71034ab63ec55d16a7a2bcb59Test
https://doi.org/10.1038/s41408-021-00587-0Test

5

Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation

المصدر: Blood, 136. AMER SOC HEMATOLOGY

مصطلحات موضوعية: medicine.medical_specialty, Neutrophil Engraftment, Cyclophosphamide, Platelet Engraftment, business.industry, Immunology, Context (language use), Cell Biology, Hematology, medicine.disease, Biochemistry, Transplantation, Internal medicine, medicine, Cumulative incidence, Progression-free survival, business, Multiple myeloma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::687293ef3a13c44c05829e19f4be224bTest
https://research.rug.nl/en/publications/b17f9094-cba5-4b80-8e63-796226a8a435Test

6

Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation

المساهمون: Hematology, CCA - Cancer Treatment and quality of life, Sahebi, F., Eikema, D. -J., Koster, L., Kroger, N., Meijer, E., van Doesum, J. A., Rovira, M., Koc, Y., Angelucci, E., Blaise, D., Sammassimo, S., Mcdonald, A., Arroyo, C. H., Sanchez, J. F., Forcade, E., Castagna, L., Stolzel, F., Sanz, J., Tischer, J., Ciceri, F., Valcarcel, D., Proia, A., Hayden, P. J., Beksac, M., Yakoub-Agha, I., Schonland, S.

المصدر: Sahebi, F, Eikema, D-J, Koster, L, Kroger, N, Meijer, E, van Doesum, J A, Rovira, M, Koc, Y, Angelucci, E, Blaise, D, Sammassimo, S, McDonald, A, Arroyo, C H, Sanchez, J F, Forcade, E, Castagna, L, Stölzel, F, Sanz, J, Tischer, J, Ciceri, F, Valcarcel, D, Proia, A, Hayden, P J, Beksac, M, Yakoub-Agha, I & Schönland, S 2021, ' Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation : First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation: F. Sahebi et al ', Transplantation and Cellular Therapy, vol. 27, no. 12, pp. 999.e1-999.e10 . https://doi.org/10.1016/j.jtct.2021.09.008Test
Transplantation and cellular therapy, 27(12), 999.e1-999.e10
Transplantation and Cellular Therapy, 27(12), 999.e1-999.e10. Elsevier BV